Stroke imaging specialist RapidAI hires new CEO

Matt O'Connor | | Health Imaging | Practice Management
karim_karti3_copy.jpg
Karim Karti. Photo: RapidAI.

RapidAI, a leading neurovascular and cardiac imaging specialist, has hired Karim Karti as its new chief executive officer, the firm said Monday.

Karti has more than 25 years of experience leading medical technology companies, including 22 years at GE Healthcare Imaging, where he served as president and CEO. He also worked as chief operating officer for iRhythm Technologies, a San Francisco-based company focused on cardiac monitoring and artificial intelligence solutions.

“I am proud and humbled to join … the whole team at RapidAI in their mission to improve the diagnosis and treatment of life-threatening conditions,” Karti said in an announcement. “I look forward to bringing my own experience in imaging, artificial intelligence and digital health to help push the boundaries of clinical technology and patient care even further and continue to save lives.”

RapidAI, based in Menlo Park, California, has received multiple Food and Drug Administration clearances for its automated imaging platforms, including a tool used to spot suspected large vessel occlusions and another machine learning system that improves stroke care. The former received New Technology Add-on Payment approval from CMS back in 2020.  

""
Matt O'Connor

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Related Content

Newly launched report feature provides patients with a visual aid to their imaging
Center for Devices and Radiological Health hit with federal job cuts
Overview of the regulatory landscape of AI in radiology
Concerns about private equity's growing influence in radiology
'Ad hoc' shifts and radiology 'maestros': How one department addressed its workflow hiccups
Not all lead glasses are created equal

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.